StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.38−0.47 (-25.41%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

Cel Sci revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2014 it was $264.03K, up 65.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2014Sep 30, 2014$264.03K+65.5%
FY2013Sep 30, 2013$159.58K-37.3%
FY2012Sep 30, 2012$254.61K-73.4%
FY2011Sep 30, 2011$956.15K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2017CQ2 2017Jun 30, 2017$17.39K–

More Cel Sci figures

See a number that looks wrong?